Life science companies are investing more in IT, with 70% telling Deloitte that cybersecurity threats will have the greatest impact on their company in the next year. And yet, many companies are slow to adopt practices to prevent potential cyberthreats.
Cloud hosting, AI, virtual care, M&A, and other innovations are accelerating R&D and pharmaceutical testing like never before, but cybersecurity needs are often overlooked or identified too late.
Read this white paper to learn how Akamai can partner with you for the right solutions, expertise, and resources.
